STARHEALTH - Swing Trade Analysis

Last Updated Time : 02 Aug 25, 12:58 am

Swing Trade Rating: 3.4

📊 Technical & Momentum Analysis

Current Price (₹436) is slightly above the 50-DMA (₹431) but below the 200-DMA (₹447) — indicating a neutral-to-weak technical setup.

RSI (51.2): Neutral — neither overbought nor oversold, suggesting indecision.

MACD (1.41): Mildly positive — early signs of momentum, but not strong.

Volume: Significantly below weekly average — low conviction from traders.

📈 Fundamental Overview

P/E (43.4) vs Industry PE (39.0): Slightly overvalued — premium pricing.

PEG Ratio (1.15): Reasonable — valuation aligns with expected growth.

ROCE (11.9%) & ROE (9.57%): Moderate — not ideal for short-term swing setups.

EPS (₹10.0): Decent earnings base.

Dividend Yield (0.00%): No passive income — purely a capital appreciation play.

Quarterly Profit Drop (-17.7%): Recent decline in performance — a cautionary signal.

Institutional Activity: FII ↓ (-4.80%), DII ↑ (+5.64%) — mixed sentiment, with domestic support but foreign outflows.

⚖️ Swing Trade Suitability

Pros

Price near key moving averages — potential for bounce.

RSI and MACD show early signs of recovery.

PEG ratio is acceptable.

DII accumulation suggests domestic confidence.

Cons

Weak volume and momentum.

Below 200-DMA — long-term resistance overhead.

Recent earnings decline and FII selling.

No dividend or book value support.

🎯 Optimal Entry Price

Entry Zone: ₹425–₹430 — near 50-DMA support. Enter only if volume picks up and RSI crosses 55.

🚪 Exit Strategy

If Holding: Consider exiting near ₹460–₹470 — resistance zone just below 200-DMA.

Stop Loss: ₹415 — breach below this level would invalidate the swing setup.

STARHEALTH is a cautious swing candidate with a neutral technical posture and mixed fundamentals. It may offer a short-term bounce, but confirmation is key. If you're already in, you're near support — just monitor momentum closely.

Edit in a page